Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Toxicology and Applied Pharmacology|October 1, 1989
Slow release delivery of rioprostil by an osmotic pump inhibits the formation of acute aspirin-induced gastric lesions in dogs and accelerates the healing of chronic lesions without incidence of side effectsL B Katz, D A ShriverThe Journal of Pharmacology and Experimental Therapeutics|November 1, 1989
Rioprostil heals pre-existing aspirin-induced gastric lesions in dogs during daily aspirin administration without altering the anti-inflammatory or analgesic efficacy of aspirinL B Katz, D A ShriverLife Sciences|September 15, 1986
Antiulcer effect of rioprostil, a prostaglandin E1 analog, in combination with antacidL B Katz, T Genna, D A ShriverClinical and Investigative Medicine. Medecine Clinique Et Experimentale|May 1, 1987
Morphological and physiological effects of a cytoprotective prostaglandin analog (rioprostil) on the rat gastric mucosaG P Morris, C M Keenan, D A ShriverThe Journal of Pharmacology and Experimental Therapeutics|July 1, 1980
Suprofen, a new peripheral analgesicR J Capetola, D A Shriver, M E RosenthaleScandinavian Journal of Gastroenterology. Supplement|January 1, 1989
Gastric antisecretory and antigastrolesive pharmacology of rioprostilD A Shriver, L B Katz, M E RosenthaleJournal of Pharmacological Methods|December 1, 1987
Use of a five-day test to predict the long-term effects of gastric antisecretory agents on serum gastrin in ratsL B Katz, R A Schoof, D A ShriverArchives Internationales De Pharmacodynamie Et De Therapie|May 1, 1986
Pharmacological profile of etintidine, a new histamine H2-receptor antagonistC K Scott, L B Katz, D A ShriverThe Journal of Pharmacology and Experimental Therapeutics|August 1, 1987
Effects of ORF 17583, other histamine H2-receptor antagonists and omeprazole on gastric acid secretory states in rats and dogsL B Katz, A J Tobia, D A ShriverThe Journal of Pharmacology and Experimental Therapeutics|August 1, 1986
Pharmacological comparison of ORF 17910, a potent, long-acting histamine H2-receptor antagonist, to cimetidine and ranitidineL B Katz, C K Scott, D A ShriverPageof 3